Search
Showing results for "Au"
By participating in ORIGINS, you are contributing to one of the largest and most comprehensive birth cohort studies ever.
News & Events
Who are our technology researchers and what do they do?A new Q&A series focusing on the different research themes within the Children’s Diabetes Centre - technology.
News & Events
Illuminate Sundowner 2024Illuminate Awards are a philanthropic initiative - shining a light on child health research to help all kids lead happy, healthy lives.
News & Events
Meet the Researcher: Dr Samantha CarlsonDr Samantha Carlson is an early career mixed-methods social scientist, leading research that seeks to understand how to improve access to and understanding about vaccination.
News & Events
Meet the Researcher: Hannah MooreAfter 20 years at the Institute, Hannah’s career has been a whirlwind of discovery and dedication.
For thousands of children around Australia with intellectual and other disabilities, the process of eating can be traumatic, posing challenges that veer from uncomfortable to life threatening.
Research
Influence of maternal and infant technology use and other family factors on infant developmentSteve Desiree Zubrick Silva FASSA, FAAMHS, MSc AM PhD MBBS, FRACP, MPH, PhD Honorary Emeritus Research Fellow Co-Head, ORIGINS 08 6319 1409
Research
Excess Mortality Among People With Rheumatic Heart Disease in AustraliaJonathan Carapetis AM AM MBBS FRACP FAFPHM PhD FAHMS Executive Director; Co-Head, Strep A Translation; Co-Founder of REACH 08 6319 1000 contact@
Research
Inter-rater reliability and agreement of the General Movement Assessment and Motor Optimality Score-Revised in a large population-based samplePrechtl's General Movement Assessment (GMA) at fidgety age (3-5 months) is a widely used tool for early detection of cerebral palsy. Further to GMA classification, detailed assessment of movement patterns at fidgety age is conducted with the Motor Optimality Score-Revised.
Research
Could late-latent syphilis be treated with a single subcutaneous infusion of long-acting penicillin?Syphilis is an important global health threat and little has changed in its treatment since the mid-20th century. For late-latent or syphilis infection of unknown duration, the standard treatment of multiple intramuscular injections of benzathine penicillin G (BPG) are associated with significant pain and distress to clients and caregivers, negatively impacting on treatment completion.